The discourse often presents a binary: AI plateaus below human level or undergoes a runaway singularity. A plausible but overlooked alternative is a "superhuman plateau," where AI is vastly superior to humans but still constrained by physical limits, transforming society without becoming omnipotent.

The development of superintelligence is unique because the first major alignment failure will be the last. Unlike other fields of science where failure leads to learning, an unaligned superintelligence would eliminate humanity, precluding any opportunity to try again.

Emmett Shear argues that even a successfully 'solved' technical alignment problem creates an existential risk. A super-powerful tool that perfectly obeys human commands is dangerous because humans lack the wisdom to wield that power safely. Our own flawed and unstable intentions become the source of danger.

If AI alignment turns out to be easy, it would likely be because morality is not a human construct but an objective feature of reality. In this scenario, any sufficiently intelligent agent would logically deduce that cooperation and preserving humanity are optimal strategies, regardless of its initial programming.

A common misconception is that a super-smart entity would inherently be moral. However, intelligence is merely the ability to achieve goals. It is orthogonal to the nature of those goals, meaning a smarter AI could simply become a more effective sociopath.

OpenAI's Boaz Barak advises individuals to treat AI risk like the nuclear threat of the past. While society should worry about tail risks, individuals should focus on the high-probability space where their actions matter, rather than being paralyzed by a small probability of doom.

AI will create negative consequences, like the internet spawned the dark web. However, its potential to solve major problems like disease and energy scarcity makes its development a net positive for society, justifying the risks that must be managed along the way.

There is a fundamental asymmetry in AI's impact. Benefits like new cancer drugs do not prevent catastrophic risks like an engineered pandemic. However, a catastrophic event makes a world with cancer drugs irrelevant. Therefore, downside mitigation must be the absolute priority.

The most likely future is a "weird" state we can't easily classify as good or bad. Rather than comparing today to a hypothetical endpoint, we should focus on evaluating the desirability of the path, or trajectory, we are on.